References
- Aanouz, I., Belhassan, A., El Khatabi, K., Lakhlifi, T., El Idrissi, M., & Bouachrine, M. (2020). Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1758790
- Abdelli, I., Hassani, F., Bekkel Brikci, S., & Ghalem, S. (2020). In silico study the inhibition of Angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from western Algeria. Journal of Biomolecular Structure and Dynamics, 1–17. https://doi.org/https://doi.org/10.1080/07391102.2020.1763199
- Afar, D. E., Vivanco, I., Hubert, R. S., Kuo, J., Chen, E., Saffran, D. C., Raitano, A. B., & Jakobovits, A. (2001). Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Research, 61(4), 1686–1692.
- Al-Khafaji, K., Al-DuhaidahawiL, D., & Taskin Tok, T. (2020). Using integrated computational approaches to identify safe and rapid treatment for SARS -CoV- 2. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1764392
- Amoros, M., Lurton, E., Boustie, J., Girre, L., Sauvager, F., & Cormier, M. (1994). Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. Journal of Natural Products, 57(5), 644–647. https://doi.org/https://doi.org/10.1021/np50107a013
- Azouz, N. P., Klingler, A. M., & Rothenberg, M. E. (2020). Alpha 1 antitrypsin is an inhibitor of the SARS-CoV2-priming protease TMPRSS2. bioRxiv, 1–16. https://doi.org/https://doi.org/10.1101/2020.05.04.077826
- Bahgat, M. M., Błazejewska, P., & Schughart, K. (2011). Inhibition of lung serine proteases in mice: A potentially new approach to control influenza infection. Virology Journal, 8(1), 27. https://doi.org/https://doi.org/10.1186/1743-422X-8-27
- Balkrishna, A., Pokhrel, S., Singh, J., & Varshney, A. (2020). Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor. Virology Journal, (Preprint), 1–26. https://doi.org/https://doi.org/10.21203/rs.3.rs-17806/v1
- Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 4(6), 1011–1033. https://doi.org/https://doi.org/10.3390/v4061011
- Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti, S., & Ciccozzi, M. (2020). The 2019-new coronavirus epidemic: Evidence for virus evolution. Journal of Medical Virology, 92(4), 455–459. https://doi.org/https://doi.org/10.1002/jmv.25688
- Bertram, S., Glowacka, I., Müller, M. A., Lavender, H., Gnirss, K., Nehlmeier, I., Niemeyer, D., He, Y., Simmons, G., Drosten, C., Soilleux, E. J., Jahn, O., Steffen, I., & Pöhlmann, S. (2011). Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. Journal of Virology, 85(24), 13363–13372. https://doi.org/https://doi.org/10.1128/JVI.05300-11
- Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1758788
- Böttcher, E., Freuer, C., Steinmetzer, T., Klenk, H. D., & Garten, W. (2009). MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine, 27(45), 6324–6329. https://doi.org/https://doi.org/10.1016/j.vaccine.2009.03.029
- Böttcher-Friebertshäuser, E., Freuer, C., Sielaff, F., Schmidt, S., Eickmann, M., Uhlendorff, J., Steinmetzer, T., Klenk, H. D., & Garten, W. (2010). Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. Journal of Virology, 84(11), 5605–5614. https://doi.org/https://doi.org/10.1128/JVI.00140-10
- Böttcher-Friebertshäuser, E., Klenk, H. D., & Garten, W. (2013). Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium. Pathogens and Disease, 69(2), 87–100. https://doi.org/https://doi.org/10.1111/2049-632X.12053
- Böttcher-Friebertshäuser, E., Lu, Y., Meyer, D., Sielaff, F., Steinmetzer, T., Klenk, H. D., & Garten, W. (2012). Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections. Vaccine, 30(51), 7374–7380. https://doi.org/https://doi.org/10.1016/j.vaccine.2012.10.001
- Böttcher-Friebertshäuser, E., Stein, D. A., Klenk, H. D., & Garten, W. (2011). Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. Journal of Virology, 85(4), 1554–1562. https://doi.org/https://doi.org/10.1128/JVI.01294-10
- Cai, Z., Zhang, G., Tang, B., Liu, Y., Fu, X., & Zhang, X. (2015). Promising anti-influenza properties of active constituent of Withania somnifera ayurvedic herb in targeting neuraminidase of H1N1 influenza: Computational study. Cell Biochemistry and Biophysics, 72(3), 727–739. https://doi.org/https://doi.org/10.1007/s12013-015-0524-9
- Ceraolo, C., & Giorgi, F. M. (2020). Genomic variance of the 2019-nCoV coronavirus. Journal of Medical Virology, 92(5), 522–528. https://doi.org/https://doi.org/10.1002/jmv.25700
- Chang, Y. C., Tung, Y. A., Lee, K. H., Chen, T. F., Hsiao, Y. C., Chang, H. C., Hsieh, T. T., Su, C. H., Wang, S. S., Yu, J. Y., & Shih, S. S. (2020). Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking. Preprints. https://doi.org/https://doi.org/10.20944/preprints202002.0242.v1
- Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 1–18. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201
- Elfiky, A. A. (2020). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1761882
- Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1758791
- Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 1–7. https://doi.org/https://doi.org/10.1080/07391102.2020.1760136
- FDA News Release. (2020). Coronavirus (COVID-19) update: FDA Issues emergency use authorization for potential COVID-19 treatment. Retrieved May 01, 2020, from https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-issues-emergencyuse-authorization-potential-covid-19-treatment
- Foulds, C. E., Tsimelzon, A., Long, W., Le, A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2010). Research resource: Expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. Molecular Endocrinology (Baltimore, MD), 24(5), 1090–1105. https://doi.org/https://doi.org/10.1210/me.2009-0427
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
- Gao, R., Shah, N., Lee, J. S., Katiyar, S. P., Li, L., Oh, E., Sundar, D., Yun, C. O., Wadhwa, R., & Kaul, S. C. (2014). Withanone-rich combination of Ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K. Molecular Cancer Therapeutics, 13(12), 2930–2940. https://doi.org/https://doi.org/10.1158/1535-7163.MCT-14-0324
- Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1751300
- Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020). Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 1–19. https://doi.org/https://doi.org/10.1080/07391102.2020.1764868
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., & Shahpasand, K. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1754293
- Hendaus, M. A. (2020). Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1767691
- Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.052
- Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30183-5
- Islam, R., Parves, R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–20. https://doi.org/https://doi.org/10.1080/07391102.2020.1761883
- Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019). TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. Journal of Virology, 93(6), e01815–18. https://doi.org/https://doi.org/10.1128/JVI.01815-18
- Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.1760137
- Kaul, S. C., Ishida, Y., Tamura, K., Wada, T., Iitsuka, T., Garg, S., Kim, M., Gao, R., Nakai, S., Okamoto, Y., Terao, K., & Wadhwa, R. (2016). Novel methods to generate active ingredients-enriched Ashwagandha leaves and extracts. PLoS One, 11(12), e0166945. https://doi.org/https://doi.org/10.1371/journal.pone.0166945
- Kaur, A., Singh, B., Ohri, P., Wang, J., Wadhwa, R., Kaul, S. C., Pati, P. K., & Kaur, A. (2018). Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost. PLoS One, 13(4), e0194314. https://doi.org/https://doi.org/10.1371/journal.pone.0194314
- Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012). Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. Journal of Virology, 86(12), 6537–6545. https://doi.org/https://doi.org/10.1128/JVI.00094-12
- Khan, R. J., Jha, R. K., Amera, G., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2’-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577
- Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1751298
- Kim, T. S., Heinlein, C., Hackman, R. C., & Nelson, P. S. (2006). Phenotypic analysis of mice lacking the Tmprss2-encoded protease. Molecular and Cellular Biology, 26(3), 965–975. https://doi.org/https://doi.org/10.1128/MCB.26.3.965-975.2006
- Konar, A., Shah, N., Singh, R., Saxena, N., Kaul, S. C., Wadhwa, R., & Thakur, M. K. (2011). Protective role of Ashwagandha leaf extract and its component Withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One, 6(11), e27265. https://doi.org/https://doi.org/10.1371/journal.pone.0027265
- Kumar, D., Kumari, K., Jayaraj, A., Kumar, V., Kumar, R. V., Dass, S. K., Chandra, R., & Singh, P. (2020). Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1752310
- Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020). Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Journal of Biomolecular Structure and Dynamics, 1–17. https://doi.org/https://doi.org/10.1080/07391102.2020.1772108
- Kwon, M. J., Shin, H. M., Perumalsamy, H., Wang, X., & Ahn, Y. J. (2019). Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds. Journal of Apicultural Research, 1–13. https://doi.org/https://doi.org/10.1080/00218839.2019.1695715
- Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges . Internatinal Journal of Antimicrobial Agents, 55(3), 105924. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2020.105924
- Laporte, M., & Naesens, L. (2017). Airway proteases: An emerging drug target for influenza and other respiratory virus infections. Current Opinion in Virology, 24, 16–24. https://doi.org/https://doi.org/10.1016/j.coviro.2017.03.018
- Latheef, S. K., Dhama, K., Samad, H. A., Wani, M. Y., Kumar, M. A., Palanivelu, M., Malik, Y. S., Singh, S. D., & Singh, R. (2017). Immunomodulatory and prophylactic efficacy of herbal extracts against experimentally induced chicken infectious anaemia in chicks: Assessing the viral load and cell mediated immunity. VirusDisease, 28(1), 115–120. https://doi.org/https://doi.org/10.1007/s13337-016-0355-3
- Lee, M. G., Kim, K. H., Park, K. Y., & Kim, J. S. (1996). Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses. Archives of Virology, 141(10), 1979–1989. https://doi.org/https://doi.org/10.1007/BF01718208
- Li, F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology, 3(1), 237–261. https://doi.org/https://doi.org/10.1146/annurev-virology-110615-042301
- Li, X., Wang, W., Zhao, X., Zai, J., Zhao, Q., Li, Y., & Chaillon, A. (2020). Transmission dynamics and evolutionary history of 2019-nCoV. Journal of Medical Virology, 92(5), 501–511. https://doi.org/https://doi.org/10.1002/jmv.25701
- Li, X., Zai, J., Wang, X., & Li, Y. (2020). Potential of large “first generation” human-to-human transmission of 2019-nCoV. Journal of Medical Virology, 92(4), 448–454. https://doi.org/https://doi.org/10.1002/jmv.25693
- Limburg, H., Harbig, A., Bestle, D., Stein, D. A., Moulton, H. M., Jaeger, J., Janga, H., Hardes, K., Koepke, J., Schulte, L., Koczulla, A. R., Schmeck, B., Klenk, H.-D., & Böttcher-Friebertshäuser, E. (2019). TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes. Journal of Virology, 93(21), e00649–19. https://doi.org/https://doi.org/10.1128/JVI.00649-19
- Lin, B., Ferguson, C., White, J. T., Wang, S., Vessella, R., True, L. D., Hood, L., & Nelson, P. S. (1999). Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Research, 59(17), 4180–4184.
- Lobo-Galo, N., Terrazas-López, M., Martínez-Martínez, A., & Díaz-Sánchez, Á. G. (2020). FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1764393
- Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. The Lancet, 395(10224), 565–574. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30251-8
- Munagala, R., Kausar, H., Munjal, C., & Gupta, R. C. (2011). Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis, 32(11), 1697–1705. https://doi.org/https://doi.org/10.1093/carcin/bgr192
- Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802
- Nejadi Babadaei, M. M., Hasan, A., Haj Bloukh, S., Edis, Z., Sharifi, M., Kachooei, E., & Falahati, M. (2020). The expression level of angiotensin-converting enzyme 2 determine the severity of COVID-19: Lung and heart tissue as targets. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1767211
- Nejadi Babadaei, M. M., Hasan, A., Vahdani, Y., Haj Bloukh, S., Sharifi, M., Kachooei, E., Haghighat, S., & Falahati, M. (2020). Development of Remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1767210
- Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1757510
- Paoloni-Giacobino, A., Chen, H., Peitsch, M. C., Rossier, C., & Antonarakis, S. E. (1997). Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics, 44(3), 309–320. https://doi.org/https://doi.org/10.1006/geno.1997.4845
- Paraskevis, D., Kostaki, E. G., Magiorkinis, G., Panayiotakopoulos, G., Sourvinos, G., & Tsiodras, S. (2020). Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 79, 104212. https://doi.org/https://doi.org/10.1016/j.meegid.2020.104212
- Park, Y. (2011). TMPRSS2 (transmembrane protease, serine 2). Atlas of Genetics and Cytogenetics in Oncology and Haematology, 14(12), 1163–1165. https://doi.org/https://doi.org/10.4267/2042/44922
- Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1753580
- Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/https://doi.org/10.1007/s10822-013-9644-8
- Schrödinger. (2020). Schrödinger Release 2020-1: Maestro 019-3 SR, Glide, LigPrep, Protein Preparation Wizard, Prime, Desmond Molecular Dynamics System, Maestro-Desmond Interoperability Tools. Schrödinger, LLC.
- Serkedjieva, J., Manolova, N., & Bankova, V. (1992). Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). Journal of Natural Products, 55(3), 294–302. https://doi.org/https://doi.org/10.1021/np50081a003
- Shen, L. W., Mao, H. J., Wu, Y. L., Tanaka, Y., & Zhang, W. (2017). TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie, 142, 1–10. https://doi.org/https://doi.org/10.1016/j.biochi.2017.07.016
- Shen, L. W., Qian, M. Q., Yu, K., Narva, S., Yu, F., Wu, Y. L., & Zhang, W. (2020). Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression. Scientific Reports, 10(1), 7635. https://doi.org/https://doi.org/10.1038/s41598-020-64368-8
- Shirato, K., Kanou, K., Kawase, M., & Matsuyama, S. (2017). Clinical isolates of human coronavirus 229E bypass the endosome for cell entry. Journal of Virology, 91(1), e01387–16. https://doi.org/https://doi.org/10.1128/JVI.01387-16
- Shirato, K., Kawase, M., & Matsuyama, S. (2013). Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. Journal of Virology, 87(23), 12552–12561. https://doi.org/https://doi.org/10.1128/JVI.01890-13
- Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., & Gallagher, T. (2011). A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of Virology, 85(2), 873–882. https://doi.org/https://doi.org/10.1128/JVI.02062-10
- Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020). An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1762741
- Thuy, B. T. P., My, T. T. A., Hai, N. T. T., Hieu, L. T., Hoa, T. T., Thi Phuong Loan, H., Triet, N. T., Anh, T. T. V., Quy, P. T., Tat, P. V., Hue, N. V., Quang, D. T., Trung, N. T., Tung, V. T., Huynh, L. K., & Nhung, N. T. A. (2020). Investigation into SARS-CoV-2 Resistance of compounds in garlic essential oil. ACS Omega, 5(14), 8312–8320. https://doi.org/https://doi.org/10.1021/acsomega.0c00772
- Umesh, D. K., Selvaraj, C., Singh, S. K., & Dubey, V. K. (2020). Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1763202
- Wadhwa, R., Konar, A., & Kaul, S. C. (2016). Nootropic potential of Ashwagandha leaves: Beyond traditional root extracts. Neurochemistry International, 95, 109–118. https://doi.org/https://doi.org/10.1016/j.neuint.2015.09.001
- Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.1762743
- Wang, Z., Chen, X., Lu, Y., Chen, F., & Zhang, W. (2020). Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Bioscience Trends, 14(1), 64–68. https://doi.org/https://doi.org/10.5582/bst.2020.01030
- WHO Coronavirus Disease (COVID-19) Dashboard. (2020). Retrieved May 21, 2020, from https://covid19.who.int.
- Widodo, N., Shah, N., Priyandoko, D., Ishii, T., Kaul, S. C., & Wadhwa, R. (2009). Deceleration of senescence in normal human fibroblasts by Withanone extracted from ashwagandha leaves. Journal of Gerontology A Biological Sciences and Medical Sciences, 64(10), 1031–1038. https://doi.org/https://doi.org/10.1093/gerona/glp088
- Widodo, N., Takagi, Y., Shrestha, B. G., Ishii, T., Kaul, S. C., & Wadhwa, R. (2008). Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses. Cancer Letters, 262(1), 37–47. https://doi.org/https://doi.org/10.1016/j.canlet.2007.11.037
- Wilson, S., Greer, B., Hooper, J., Zijlstra, A., Walker, B., Quigley, J., & Hawthorne, S. (2005). The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. The Biochemical Journal, 388(Pt 3), 967–972. https://doi.org/https://doi.org/10.1042/BJ20041066
- Yamaya, M., Shimotai, Y., Hatachi, Y., Lusamba Kalonji, N., Tando, Y., Kitajima, Y., Matsuo, K., Kubo, H., Nagatomi, R., Hongo, S., Homma, M., & Nishimura, H. (2015). The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells. Pulmonary Pharmacology & Therapeutics, 33, 66–74. https://doi.org/https://doi.org/10.1016/j.pupt.2015.07.001
- Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Jr., Nunneley, J. W., Barnard, D., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., & Simmons, G. (2015). Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research, 116, 76–84. https://doi.org/https://doi.org/10.1016/j.antiviral.2015.01.011
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W, & China Novel Coronavirus Investigating and Research Team. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017